In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Recommanded Product: Methyl 6-chloropyridazine-3-carboxylate, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 65202-50-8, name is Methyl 6-chloropyridazine-3-carboxylate. In an article,Which mentioned a new discovery about 65202-50-8
Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA Desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome
Stearoyl-CoA desaturase-1 (SCD1) catalyzes de novo synthesis of monounsaturated fatty acids from saturated fatty acids. Studies have demonstrated that rodents lacking a functional SCD1 gene have an improved metabolic profile, including reduced weight gain, lower triglycerides, and improved insulin response. In this study, we discovered a series of piperazinylpyridazine-based highly potent, selective, and orally bioavailable compounds. Particularly, compound 49 (XEN103) was highly active in vitro (mSCD1 IC50 = 14 nM and HepG2 IC50 = 12 nM) and efficacious in vivo (ED50 = 0.8 mg/kg). It also demonstrated striking reduction of weight gain in a rodent model. Our findings with small-molecule SCD1 inhibitors confirm the importance of this target in metabolic regulation, describe novel models for assessing SCD1 inhibitors for efficacy and tolerability and demonstrate an opportunity to develop a novel therapy for metabolic disease.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 65202-50-8, help many people in the next few years.Recommanded Product: Methyl 6-chloropyridazine-3-carboxylate
Reference:
Pyridazine – Wikipedia,
Pyridazine | C4H4N2444 – PubChem